Meeder Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,852
| Closed | -$31.5K | – | 1011 |
|
|
2025
Q1 | $31.5K | Hold |
6,852
| – | – | ﹤0.01% | 461 |
|
|
2024
Q4 | $32.8K | Hold |
6,852
| – | – | ﹤0.01% | 440 |
|
|
2024
Q3 | $32.1K | Hold |
6,852
| – | – | ﹤0.01% | 432 |
|
|
2024
Q2 | $38.7K | Buy |
+6,852
| New | +$38.7K | ﹤0.01% | 386 |
|
|
2022
Q4 | – | Sell |
-154
| Closed | -$2K | – | 1987 |
|
|
2022
Q3 | $2K | Buy |
154
+39
| +34% | +$506 | ﹤0.01% | 1870 |
|
|
2022
Q2 | $1K | Buy |
115
+49
| +74% | +$426 | ﹤0.01% | 2093 |
|
|
2022
Q1 | $1K | Buy |
+66
| New | +$1K | ﹤0.01% | 2257 |
|
|
2021
Q4 | – | Sell |
-4,435
| Closed | -$77K | – | 2316 |
|
|
2021
Q3 | $77K | Buy |
4,435
+4,322
| +3,825% | +$75K | ﹤0.01% | 975 |
|
|
2021
Q2 | $2K | Sell |
113
-880
| -89% | -$15.6K | ﹤0.01% | 2262 |
|
|
2021
Q1 | $14K | Buy |
993
+970
| +4,217% | +$13.7K | ﹤0.01% | 1522 |
|
|
2020
Q4 | $0 | Sell |
23
-5,638
| -100% | – | ﹤0.01% | 2245 |
|
|
2020
Q3 | $55K | Buy |
5,661
+2,502
| +79% | +$24.3K | ﹤0.01% | 938 |
|
|
2020
Q2 | $36K | Buy |
3,159
+2,259
| +251% | +$25.7K | ﹤0.01% | 992 |
|
|
2020
Q1 | $9K | Sell |
900
-9,666
| -91% | -$96.7K | ﹤0.01% | 1582 |
|
|
2019
Q4 | $173K | Buy |
10,566
+5,351
| +103% | +$87.6K | 0.01% | 639 |
|
|
2019
Q3 | $69K | Buy |
5,215
+4,915
| +1,638% | +$65K | ﹤0.01% | 909 |
|
|
2019
Q2 | $4K | Sell |
300
-7,992
| -96% | -$107K | ﹤0.01% | 1744 |
|
|
2019
Q1 | $153K | Buy |
8,292
+174
| +2% | +$3.21K | 0.01% | 601 |
|
|
2018
Q4 | $211K | Sell |
8,118
-3,299
| -29% | -$85.7K | 0.02% | 487 |
|
|
2018
Q3 | $261K | Buy |
11,417
+7,102
| +165% | +$162K | 0.02% | 461 |
|
|
2018
Q2 | $82.2K | Buy |
4,315
+1,293
| +43% | +$24.6K | 0.01% | 659 |
|
|
2018
Q1 | $50K | Sell |
3,022
-453
| -13% | -$7.5K | ﹤0.01% | 676 |
|
|
2017
Q4 | $53K | Buy |
3,475
+523
| +18% | +$7.98K | ﹤0.01% | 679 |
|
|
2017
Q3 | $53K | Buy |
2,952
+1,867
| +172% | +$33.5K | 0.01% | 676 |
|
|
2017
Q2 | $18K | Buy |
+1,085
| New | +$18K | ﹤0.01% | 850 |
|